[ Price : $8.95]
PhRMA suggests ways FDA can improve its efforts to standardize REMS.[ Price : $8.95]
Hyman, Phelps & McNamara asks FDA to designate one of four ANDA-approved companies making cefdinir for oral suspension as a second...[ Price : $8.95]
FDAs Chicago District Office warns Y.S. Health about violations of dietary supplement CGMP regulations as well as distributing una...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Brower Enterprises, Gum Runners, and Y.S. Health.[ Price : $8.95]
FDA grants Genmab and GlaxoSmithKline a breakthrough therapy designation for Arzerra (ofatumumab) in combination with chlorambucil...[ Price : $8.95]
Hospira recalls one lot of 0.25% bupivacaine HCl Injection, USP (2.5 mg/mL), 30 mL single-dose vials due to the presence of partic...[ Price : $8.95]
FDA places another Ranbaxy drug manufacturing plant in India under terms of a 2012 consent decree after two inspections last year ...[ Price : $8.95]
Federal Register Notice: FDAs Blood Products Advisory Committee will meet 11/1 to discuss MP Biomedicals BLA for a Western blot in...